Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.85
Delayed Data
As of Aug 28
 -0.10 / -1.68%
Today’s Change
3.71
Today|||52-Week Range
10.20
+28.29%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close5.95
Today’s open5.93
Day’s range5.66 - 5.93
Volume57,151
Average volume (3 months)101,058
Market cap$67.6M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.12+9.76%
EBIOEleven Biotherapeuti...-0.08-2.20%
CAPRCapricor Therapeutic...-0.04-0.93%
BLPHBellerophon Therapeu...-0.07-1.38%
Data as of 3:59pm ET, 08/28/2015

Financials

Last reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts

Partner Offers